[ad_1]
THE European Medicines Agency proposed this Monday the conditional approval of his vaccine Pfizer / BioNTech Against him coronavirus across the EU, weeks after the urgent approval of this vaccine in Brittany and U.S.
“This is an EU moment,” said the EU Health Commissioner. Stella Kyriakidou pointing out that the European Medicines Agency Recommended conditional marketing authorization for Pfizer / BioNtech vaccine.
In particular, Ms. Kyriakidou stated:
“Now is the time for the European Union: we are one step closer to a safe and effective vaccine for COVID19. The European Health Organization has recommended a conditional marketing authorization for the Pfizer / BioNtech vaccine.” The European Commission and the Member States will urgently move forward now. “
Commission President Ursula von der Leyen spoke at a crucial moment and stressed that it was time for the EU to act quickly.
He added: “I am waiting for a decision from the Commission until evening.” More specifically, the Ursula von der Leyen set:
“This is a crucial moment in our efforts to provide safe and effective vaccines to Europeans. The European Health Agency has just issued a positive opinion on the Pfizer / BioNtech vaccine. We will now act quickly. I am awaiting a decision from the Commission until night “.
The decision was made after a closed-door meeting on Monday, with the European Medicines Agency proposing The vaccine should be given to people over the age of 16, with a few exceptions. The pharmaceutical industry will need to present advanced data on the vaccine over the next year.
Vaccine “premiere” on December 27
Both Germany and several other EU countries estimate that vaccination against the coronavirus will begin on December 27.
“Today is a special and emotional day for us at BioNTech,” said Ugur Sahin, CEO and co-founder of the company.
[ad_2]
